Open AccessFluconazole ‐ a case report on fixed drug eruption
Author(s) -
Correia Magna,
Correia Magna,
Freitas João,
Vieira Rita,
Perneta Filipe,
Brazão Luz
Publication year - 2014
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-4-s3-p72
Subject(s) - fluconazole , medicine , drug eruption , dermatology , erythema , valaciclovir , physical examination , adverse effect , surgery , drug , antifungal , pharmacology , human immunodeficiency virus (hiv) , family medicine , viral disease , herpesviridae
Background Adverse reactions to drugs, Fixed Erythema (FE), correspond to 16-21% of all skin eruptions. This disease results in the development of one or more erythematous annular or oval, plaques as a result of systemic exposure to a drug. On reexposure relapse occurs in the same place, although new lesions may arise simultaneously in other areas. Any drug can cause FE. The physiopathology involves an allergic reaction (vasculitis).